Chronic diseases among vitiligo patients

References

1. ↵
   1. Goldstein B,
   2. Goldstein A

   Vitiligo. [Internet], Available from: http://www.uptodate.com/contents/vitiligo. [updated 2015 January 19; cited 2016 April].
2. ↵
   1. Groysman V,
   2. Sami N

   Vitilgo. [Internet], Available from: http://emedicine.medscape.com/article/1068962-overview#a6. [updated 2015 June 19; cited 2016 April].
3. ↵
   1. Krüger C,
   2. Schallreuter KU

   (2012) A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol 51:1206–1212.

   OpenUrlCrossRefPubMed
4. ↵
   1. Ezzedine K,
   2. Eleftheriadou V,
   3. Whitton M,
   4. van Geel N

   (2015) Vitiligo. Lancet 386:74–84.

   OpenUrlCrossRefPubMed
5. ↵
   1. Bolognia JL,
   2. Jorizzo JL,
   3. Rapini R

   1. Ortonne J

   (2008) in Dermatology, Vitiligo and other disorders of hypopigmentation, eds Bolognia JL, Jorizzo JL, Rapini R (Elsevier, Madrid), 2nd ed.
6. ↵
   1. Gawkrodger DJ,
   2. Ormerod AD,
   3. Shaw L,
   4. Mauri-Sole I,
   5. Whitton ME,
   6. Watts MJ,
   7. et al.

   (2010) Vitiligo: Concise evidence based guidelines on diagnosis and management. Postgrad Med J 86:466–471.

   OpenUrlAbstract/FREE Full Text
7. ↵
   1. Oiso N,
   2. Suzuki T,
   3. Wataya-Kaneda M,
   4. Tanemura A,
   5. Tanioka M,
   6. Fujimoto T,
   7. et al.

   (2013) Guidelines for the diagnosis and treatment of vitiligo in Japan. J Dermatol 40:344–354.

   OpenUrlPubMed
8. ↵
   1. Thatte SS,
   2. Khopkar US

   (2014) The utility of dermoscopy in the diagnosis of evolving lesions of vitiligo. Indian J Dermatol Venereol Leprol 80:505–508.

   OpenUrl
9. ↵
   1. Lotti T,
   2. Gori A,
   3. Zanieri F,
   4. Colucci R,
   5. Moretti S

   (2008) Vitiligo: New and emerging treatments. Dermatol Ther 21:110–117.

   OpenUrlCrossRefPubMed
10. ↵
    1. Matz H,
    2. Tur E

    (2007) Vitiligo. Curr Probl Dermatol 35:78–102.

    OpenUrlPubMed
11. ↵
    1. Sheth VM,
    2. Guo Y,
    3. Qureshi AA

    (2013) Comorbidities associated with vitiligo: A ten-year retrospective study. Dermatology 227:311–315.

    OpenUrl
12. ↵
    1. Ramakrishna P,
    2. Rajni T

    (2014) Psychiatric morbidity and quality of life in vitiligo patients. Indian J Psychol Med 36:302–303.

    OpenUrl
13. ↵
    1. Paravar T,
    2. Lee DJ

    (2010) Vitiligo in an urban academic setting. Int J Dermatol 49:39–43.

    OpenUrlPubMed
14. ↵
    1. Shankar DS,
    2. Shashikala K,
    3. Madala R

    (2012) Clinical patterns of vitiligo and its associated comorbidities: A prospective controlled cross-sectional study in South India. Indian J Community Med 3:114–118.

    OpenUrl
15. ↵
    1. Alkhateeb A,
    2. Fain P,
    3. Thody A,
    4. Bennett D,
    5. Spritz R

    (2003) Epidemiology of vitiligo and associated autoimmune diseases in caucasian probands and their families. Pigment Cell Res 16:208–214.

    OpenUrlCrossRefPubMedWeb of Science
16. ↵
    1. Liu JB,
    2. Li M,
    3. Yang S,
    4. Gui JP,
    5. Wang HY,
    6. Du WH,
    7. et al.

    (2005) Clinical profiles of vitiligo in China: an analysis of 3742 patients. Clin Exp Dermatol 30:327–331.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    1. Sharma N,
    2. Koranne R,
    3. Singh R

    (2001) Psychiatric morbidity in psoriasis and vitiligo: A comparative study. J Dermatol 28:419–423.

    OpenUrlPubMed
18. ↵
    1. Lee H,
    2. Lee MH,
    3. Lee DY,
    4. Kang HY,
    5. Kim KH,
    6. Choi GS,
    7. et al.

    (2015) Prevalence of vitiligo and associated comorbidities in Korea. Yonsei Med J 56:719–725.

    OpenUrl
19. ↵
    1. Finlay AY,
    2. Khan GK

    (1994) Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol 19:210–216.

    OpenUrlCrossRefPubMedWeb of Science
20. ↵
    1. Basra MK,
    2. Sue-Ho R,
    3. Finlay AY

    (2007) The Family Dermatology Life Quality Index: measuring the secondary impact of skin disease. Br J Dermatol 156:528–538.

    OpenUrlCrossRefPubMed
21. ↵
    1. Bin Saif G,
    2. Al-Balbeesi A,
    3. Binshabaib R,
    4. Alsaad D,
    5. Kwatra S,
    6. Alzolibani A,
    7. et al.

    (2013) Quality of life in family members of vitiligo patients: A questionnaire study in Saudi Arabia. Am J Clin Dermatol 14:489.

    OpenUrl
22. ↵
    1. Alenizi D

    (2014) Consanguinity pattern and heritability of vitiligo in Arar, Saudi Arabia. J Family Community Med 21:13.

    OpenUrl
23. ↵
    1. Jarallah JS,
    2. Al-Sheikh OA,
    3. El-Shabrawy M,
    4. Al-Wakeel MA

    (1993) Vitiligo: Epidemiology and clinical pattern at King Khalid University Hospital. Ann Saudi Med 13:332–334.

    OpenUrlPubMed
24. ↵
    1. Biswas M,
    2. Chattopadhyay A,
    3. Mridha K,
    4. Biswas T,
    5. Biswas J,
    6. Hassan SK

    (2015) A study on association between vitiligo and thyroid dysfunction. IOSR-JDMS 14:34–37.

    OpenUrl
25. ↵
    1. Gopal KV,
    2. Rao GR,
    3. Kumar YH

    (2014) Increased prevalence of thyroid dysfunction and diabetes mellitus in Indian vitiligo patients: A case-control study. Indian Dermatol Online J 5:456–460.

    OpenUrl
26. ↵
    1. Pietrzak A,
    2. Bartosińska J,
    3. Dybiec E,
    4. Chodorowska G,
    5. Krasowska D,
    6. Hercogova J,
    7. et al.

    (2014) Hepato-splenic and lipid profile abnormalities-Do they exist in children affected with vitiligo. Acta Dermatovenerol Croat 22:19–25.

    OpenUrl